Literature DB >> 7546726

Application of the immunoblot technique for quantitation of protein levels in cardiac homogenates.

J M Harrer1, E Kiss, E G Kranias.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7546726

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


× No keyword cloud information.
  4 in total

1.  SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts.

Authors:  Hong-Sheng Wang; Demetrios A Arvanitis; Min Dong; Paul J Niklewski; Wen Zhao; Chi Keung Lam; Evangelia G Kranias; Despina Sanoudou
Journal:  Physiol Genomics       Date:  2011-01-25       Impact factor: 3.107

2.  Young MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy.

Authors:  Ilka Lorenzen-Schmidt; Bruno D Stuyvers; Henk E D J ter Keurs; Moto-o Date; Masahiko Hoshijima; Kenneth R Chien; Andrew D McCulloch; Jeffrey H Omens
Journal:  J Mol Cell Cardiol       Date:  2005-08       Impact factor: 5.000

3.  Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.

Authors:  Pia J Guinto; Todd E Haim; Candice C Dowell-Martino; Nathaniel Sibinga; Jil C Tardiff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-05       Impact factor: 4.733

4.  Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.

Authors:  V J Kadambi; S Ponniah; J M Harrer; B D Hoit; G W Dorn; R A Walsh; E G Kranias
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.